Neoadjuvant Nivolumab and Relatlimab in Cutaneous Squamous Cell Carcinoma

Clinical trial NCT06288191 · RECRUITING

Trial details

NCT number: NCT06288191
Sponsor: Melanoma Institute Australia
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Cutaneous Squamous Cell Carcinoma

Start date: 2024-06-21
Primary completion: 2026-09-01
Enrollment: 20

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.